Determinants of treatment adherence in ethnically diverse, economically disadvantaged patients with rheumatic disease

Journal of Rheumatology

Volumn 32, Issue 5, 2005, Pages 913-919

  Garcia Popa Lisseanu, Maria G ^a   Greisinger, Anthony ^b   Richardson, Marsha ^a,c   O'Malley, Kimberly J ^a,c   Janssen, Namieta M ^a   Marcus, Donald M ^a   Tagore, Jasmeet ^a,c   Suarez Almazor, Maria E ^a,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Kelsey Research Foundation   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Focus groups; Rheumatoid arthritis; Systemic lupus erythematosus; Treatment adherence

Indexed keywords

ADULT; CLINICAL ARTICLE; COMPUTER PROGRAM; COST; ECONOMIC ASPECT; ETHNIC DIFFERENCE; EXPERIENCE; FEMALE; HEALTH CARE SYSTEM; HUMAN; MALE; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PERCEPTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUALITATIVE ANALYSIS; REVIEW; RHEUMATIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIRHEUMATIC AGENTS; APPOINTMENTS AND SCHEDULES; ARTHRITIS, RHEUMATOID; COMMUNICATION BARRIERS; CULTURAL DIVERSITY; DRUG COSTS; FEMALE; FOCUS GROUPS; HUMANS; LANGUAGE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT SATISFACTION; POVERTY; SEVERITY OF ILLNESS INDEX; VULNERABLE POPULATIONS;

EID: 18744367255     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Evans RG, Barer ML, Marmor TR. Why are some people healthy and others not? The determinants of health of populations. New York: Aldine de Gruyter: 1994.
2. Callahan LF, Pincus T. Formal education level as a significant marker of clinical status in rheumatoid arthritis. Arthritis Rheum 1988;31:1346-57.
3. Callahan LF, Smith WJ, Pincus T. Self-report questionnaires in five rheumatic diseases: comparisons of health status constructs and associations with formal education level. Arthritis Care Res 1989;2:122-31.
4. Callahan LF, Pincus T. Associations between clinical status questionnaire scores and formal education level in persons with systemic lupus erythematosus. Arthritis Rheum 1990;33:407-11.
5. ERAS Study Group. Socioeconomic deprivation and rheumatoid disease: what lessons for the health service? Ann Rheum Dis 2000;59:794-9.
6. Gordon MM, Hampson R, Capell HA, Madhok R. Illiteracy in rheumatoid arthritis patients as determined by the Rapid Estimate of Adult Literacy in Medicine (REALM) score. Rheumatology Oxford 2002;41:750-4.
7. Jacobi CE, Mol GD, Boshuizen HC, Rupp I, Dinant HJ, Van Den Bos GA. Impact of socioeconomic status on the course of rheumatoid arthritis and on related use of health care services. Arthritis Rheum 2003;49:567-73.
8. McEntegart A, Morrison E, Capell HA, et al. Effect of social deprivation on disease severity and outcome in patients with rheumatoid arthritis. Ann Rheum Dis 1997;56:410-3.
9. Pincus T, Callahan LF. Formal education as a marker for increased mortality and morbidity in rheumatoid arthritis. J Chronic Dis 1985;38:973-84.
10. Vliet Vlieland TP, Buitenhuis NA, van Zeben D, Vandenbroucke JP, Breedveld FC, Hazes JM. Sociodemographic factors and the outcome of rheumatoid arthritis in young women. Ann Rheum Dis 1994;53:803-6.
11. Maiden N, Capell HA, Madhok R, Hampson R, Thomson EA. Does social disadvantage contribute to the excess mortality in rheumatoid arthritis patients? Ann Rheum Dis 1999;58:525-9.
12. Petri M, Perez-Gutthann S, Longenecker JC, Hochberg M. Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med 1991;91:345-53.
13. Reveille JD, Bartolucci A, Alarcon GS. Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum 1990;33:37-48.
14. Reveille JD, Moulds JM, Ahn C, et al. Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum 1998;41:1161-72.
15. Friedman AW, Alarcon GS, McGwin G, Jr., et al. Systemic lupus erythematosus in three ethnic groups. IV. Factors associated with self-reported functional outcome in a large cohort study. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Care Res 1999;12:256-66.
16. Ward MM, Pyun E, Studenski S. Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum 1995;38:274-83.
17. Karlson EW, Daltroy LH, Lew RA, et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:47-56.
18. Jordan JM. Effect of race and ethnicity on outcomes in arthritis and rheumatic conditions. Curr Opin Rheumatol 1999;11:98-103.
19. Singh N, Squier C, Sivek C, Wagener M, Nguyen MH, Yu VL. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care 1996;8:261-9.
20. Graveley EA, Oseasohn CS. Multiple drug regimens: medication compliance among veterans 65 years and older. Res Nurs Health 1991;14:51-8.
21. Tsakonas E, Fitzgerald AA, Fitzcharles MA, et al. Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study. J Rheumatol 2000;27:623-9.
22. Fries JF, Williams CA, Morfeld D, Singh G, Sibley J. Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies. Arthritis Rheum 1996;39:616-22.
23. Glave-Testino C, Cardiel MH, Arce-Salinas A, Alarcon-Segovia D. Factors associated with disease severity in Mexican patients with rheumatoid arthritis. Clin Exp Rheumatol 1994;12:589-94.
24. Lee P, Tan LJ. Drug compliance in outpatients with rheumatoid arthritis. Aust N Z J Med 1979;9:274-7.
25. Deyo RA, Inui TS, Sullivan B. Noncompliance with arthritis drugs: magnitude, correlates, and clinical implications. J Rheumatol 1981;8:931-6.
26. Belcon MC, Haynes RB, Tugwell P. A critical review of compliance studies in rheumatoid arthritis. Arthritis Rheum 1984;27:1227-33.
27. Pullar T, Peaker S, Martin MF, Bird HA, Feely MP. The use of a pharmacological indicator to investigate compliance in patients with a poor response to antirheumatic therapy. Br J Rheumatol 1988;27:381-4.
28. De Klerk E, Van Der HD, Landewe R, Van Der TH, Urquhart J, Van Der LS. Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout. J Rheumatol 2003;30:44-54.
29. Viller F, Guillemin F, Briancon S, Moum T, Suurmeijer T, van den HW. Compliance to drug treatment of patients with rheumatoid arthritis: a 3 year longitudinal study. J Rheumatol 1999;26:2114-22.
30. Corbin J, Strauss A. Basics of qualitative research: grounded theory procedures and techniques. Thousand Oaks, California: Sage; 1990.
31. Corbin J, Strauss A. Methods of qualitative research. Thousand Oaks, California: Sage; 1993.
32. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
33. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
34. Janz NK, Becker MH. The Health Belief Model: a decade later. Health Educ Q 1984;11:1-47.
35. Criswell LA, Katz PP. Relationship of education level to treatment received for rheumatoid arthritis. J Rheumatol 1994;21:2026-33.
36. Lopez-Mendez A, Paul WA, Alarcon GS. Rheumatoid arthritis in American blacks: a clinical and radiological study. J Rheumatol 1989;16:1197-200.
37. Fraenkel L, Bogardus S, Concato J, Felson D. Risk communication in rheumatoid arthritis. J Rheumatol 2003;30:443-8.
38. Mosley-Williams A, Lumley MA, Gillis M, Leisen J, Guice D. Barriers to treatment adherence among African American and white women with systemic lupus erythematosus. Arthritis Rheum 2002;47:630-8.
39. Maggiolo F, Ripamonti D, Arici C, Gregis G, Quinzan G, Camacho GA et al. Simpler regimens may enhance adherence to antiretrovirais in HIV-infected patients. HIV Clin Trials 2002;3:371-8.
40. Kiortsis DN, Giral P, Bruckert E, Turpin G. Factors associated with low compliance with lipid-lowering drugs in hyperlipidemic patients. J Clin Pharm Ther 2000;25:445-51.
41. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001;23:1296-310.
42. Mirotznik J, Ginzler E, Zagon G, Baptiste A. Using the health belief model to explain clinic appointment-keeping for the management of a chronic disease condition. J Community Health 1998;23:195-210.
43. Simpson SH, Farris KB, Johnson JA, Tsuyuki RT. Using focus groups to identify barriers to drug use in patients with congestive heart failure. Pharmacotherapy 2000;20:823-9.